Changing trends in pacemaker and implantable cardioverter defibrillator generator advisories

PACE - Pacing and Clinical Electrophysiology

Volumn 25, Issue 12, 2002, Pages 1670-1678

  Maisel, William H ^a   Stevenson, William G ^a   Epstein, Laurence M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Defibrillation; Epidemiology; Pacemakers; Postmarket surveillance

Indexed keywords

ARTICLE; ARTIFICIAL HEART PACEMAKER; COMPUTER PROGRAM; DEFIBRILLATOR; DEVICE REMOVAL; FOOD AND DRUG ADMINISTRATION; PATIENT CARE; PATIENT SATISFACTION; QUALITY CONTROL; SAFETY; STANDARD; TREATMENT OUTCOME;

EID: 0036915238     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2002.01670.x     Document Type: Article

References (25)

1. Maisel WH, Sweeney MO, Stevenson WG, et al. Recalls and safety alerts involving pacemaker and implantable cardioverter-defibrillator generators. JAMA 2001; 286:793-799.
2. Kawanishi DT, Song S, Furman S, et al., for the Bilitch Registry and STIMAREC. Failure rates of leads, pulse generators, and programmers have not diminished over the last 20 years: Formal monitoring of performance is still needed. PACE 1996; 19:1819-1823.
3. Sneed NV, Finch NJ, Leman RB. The impact of device recall on patients and family members of patients with automatic implantable cardioverter defibrillators. Heart Lung 1994; 23:317-322.
4. Llewellyn MJ, Bennett DH, Shearer KS, et al. The impact of manufacturer's revision of pacemaker service life on the workload of a large pacing center. PACE 1989; 12:1014-1017.
5. Medtronic Product Performance Report: Bradycardia Products. Medtronic, Minneapolis, MN. March 2000.
6. Medtronic Product Performance Report: Tachyarrhythmia Management. Medtronic, Shoreview, MN, No 6. November 1999.
7. Guidant Product Performance Report. Guidant Corp., St. Paul, MN. 1999.
8. Pacesetter Product Performance Report. St. Jude Medical, Sylmar, CA. December 1998.
9. Sulzer Intermedics Product Performance Report. Sulzer Intermedics Inc., Angleton, TX. November 1997.
10. Telectronics Product Performance Report: An Aid to Patient Management. Telectronics Pacing Systems, Englewood, CO. January 1996.
11. Levin PJ, Sassouni C. The potential world market for cardiovascular and medical devices. J Invasive Cardiol 1997; 9:138-143.
12. Food and Drug Administration. FDA Enforcement Report, Rockville, MD, National Press Office, February 12, 1997.
13. Food and Drug Administration. FDA Enforcement Report, Rockville, MD, National Press Office, May 5, 1999.
14. Food and Drug Administration. FDA Enforcement Report, Rockville, MD, National Press Office, December 15, 1999.
15. Song SL. Bilitch Report: Performance of implantable cardiac rhythm management devices. PACE 1994; 17:692-708.
16. Eagle KA. Safety alerts involving device therapy for arrhythmias. JAMA 2001; 286:843-844.
17. Tyers GTO. FDA Recalls: How do pacemaker manufacturers compare? Ann Thorac Surg 1989; 48:390-396.
18. Israel CW, Barold SS. Pacemaker systems as implantable cardiac rhythm monitors. Am J Cardiol 2001; 88:442-445.
19. Chang K. Study of Heart-Device Defects Puts Makers on the Defensive. New York Times, August 15, 2001, A12.
20. Goldman BS, Newman D, Fraser J, et al. Management of intracardiac device recalls: A consensus conference. PACE 1996; 19:7-17.
21. Maisel WH, Stevenson WG, Epstein LM. Safety of implantable devices. JAMA 2002; 287:839-840.
22. Maloney JD, Hayes DL, Timmis GC. Report of the policy conference of NASPE on device/lead performance and the development of a postmarket surveillance database. PACE 1993; 16:1945-1952.
23. Carpenter CM, Galvin J, Guy M, et al. Runaway pacemaker in an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 1998; 9:1008-1011.
24. Stanton MS. Safety of implantable devices. JAMA 2002; 287:839.
25. Kay GN, Brinker JA, Kawanishi DT, et al. Risks of spontaneous injury and extraction of an active fixation pacemaker lead: Report of the Accufix Multicenter Clinical Study and Worldwide Registry. Circulation 1999; 100:2344-2352.